ProSomnus Showcasing Sleep Apnea Treatment at Medical Conferences

One study compared precision oral appliance therapy with CPAP therapy as a first-line treatment for obstructive sleep apnea, the company said. Results showed that precision OAT effectively treated 90% of moderate OSA patients and 85% of severe OSA patients.

“ProSomnus proudly supports medical grade research that helps physicians select the optimal therapy for each and every patient with Obstructive Sleep Apnea,” Len Liptak, ProSomnus Co-Founder and Chief Executive Officer, said. “A growing number of physicians are interested in ProSomnus devices as an alternative to CPAP and Hypoglossal Nerve Stimulation. ProSomnus devices have demonstrated efficacy, safety, adherence, and patient preference in several studies.”